Gender effects in pharmacokinetics and pharmacodynamics.
about
Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's diseaseCytochrome P4502C9: an enzyme of major importance in human drug metabolismInfluence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteersPrednisolone pharmacokinetics and pharmacodynamics in relation to sex and raceGender and manganese exposure interactions on mouse striatal neuron morphologyGender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in ratsA prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh.Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sexPharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3The Illinois Women's Health Registry: advancing women's health research and education in Illinois, USAGender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.Trends in veterinary clinical and fundamental pharmacology: past and future in The Netherlands.Pharmacogenetics and psychopharmacotherapy.Dedication to professor Leslie Z. Benet: 50 years of scientific excellence and still going strong!Gender-based differences in pharmacokinetics in laboratory animal models.Invited review: gender issues related to spaceflight: a NASA perspective.Integrating women's human rights into global health research: an action framework.A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India.Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.Sex and age differences in the pharmacokinetics of alosetron.The distribution and gender difference of CYP3A activity in Chinese subjects.Differences between clinical trials and postmarketing use.Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activitySex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Gender-based personalized pharmacotherapy: a systematic review.Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.Gender: a possible determinant in dosing of dermatologic drugs--an overview.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Strategies to assess the drug interaction potential in translational medicine.Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro.Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish surveyGender has a small but statistically significant effect on clearance of CYP3A substrate drugs.Urinary estrogen levels in women on contraceptives in enugu, South-East Nigeria.The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism.Sex-specific differences in side effects of psychotropic drugs: genes or gender?Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties.Gender differences in antidepressant drug response.
P2860
Q24564761-A95325C0-278D-43DA-B675-315D7261D443Q24683497-31DB1728-7A42-4DFA-80FA-C463069F5FFCQ28361031-D8519E5E-ED2A-46BD-8D96-428358A7210AQ28363529-C21567C7-2CE6-43E7-96A7-EAF4474E95EDQ28391734-CDA61766-1C59-4392-985C-834AD6F7DBB2Q28571998-351C7CD0-EBA9-4DBC-8DEF-1D37F49F152EQ33616201-A276B0A1-2B0D-413D-A7BE-200CCFBEABE1Q33683890-7AB0C815-A763-43AA-98E1-B32F6C552263Q33705707-F881CF0F-71BD-415F-BCFF-4F419A7099C6Q33710324-DF853DA0-BBC3-4A4E-8C92-6A435BC4A9FAQ33763677-3378E6DA-1FE1-4204-9D4A-EB68CF8FE38CQ33807411-BE67D8B1-D951-4F95-BBFE-BBF0C0012094Q33842776-D5588CDD-E740-4926-B204-A008BD414AEBQ33962212-67A2A62B-E6CF-4376-8ED3-347E13776CA1Q34289184-C8767F3E-CC26-4DE9-8CB9-607D31BF1A36Q34327917-2A2B7FA2-217C-439C-B64F-1815BF9A6E8BQ34407675-66E2C6F6-B19A-4682-B074-5C7B77588B61Q34415657-65CE75E7-E966-4090-86A0-607B243BBA8BQ34561751-5257FD03-4122-4499-86FC-70EEB144F5F1Q34792547-E67E1006-B84D-4BB1-94EB-AA9B9143B227Q35803732-01708BAB-1B2F-4F7C-B3B7-D5CFFB685142Q35825247-BE0CA0E0-7370-420D-A4C7-B153140D6CD4Q35825899-21F56DD4-A851-4AF9-8D12-2EF0EC31B281Q35827674-C6076FE1-059E-4D39-B9DC-A86389958E1FQ35885251-F0B01B22-19B8-4855-84BD-E959917BF024Q36061821-2CF0080F-7096-4660-88EF-EEB70734A050Q36335289-40CA9946-C74A-47B9-BE65-73BBC5A32FB7Q36544972-82E090F2-683F-4AC8-A088-E33DF3CD52B9Q36596188-955A8636-E6EB-49AB-BCE4-541FF63E0FF1Q36603317-435A5D65-6210-4167-8627-AD1EBC4704F4Q36609743-7BE8DF7A-0CE4-4179-9F47-FD37B0197E5BQ36989348-AD6E7D82-E76B-4609-A292-7E1D919F3275Q37144642-0AD6919C-9805-4A4C-9343-29280F9C0DD3Q37190932-4D328111-73C0-4FB3-80B9-AF7F42D73CCAQ37256195-8E90B357-A204-4828-B01E-14E31F2E38CFQ37487199-B5015100-7640-46E5-87EC-A08C2A8E7CA0Q37523782-83370F9E-6C7B-46FB-AE32-5CEE5E156122Q37598900-525C772F-5C16-4F1B-887A-3B7040B67996Q37761376-A0888B72-6E31-48B4-BDF0-AB074EB6485DQ37806757-8DCD63E2-479E-4505-A226-26ADFE0B87B9
P2860
Gender effects in pharmacokinetics and pharmacodynamics.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Gender effects in pharmacokinetics and pharmacodynamics.
@en
type
label
Gender effects in pharmacokinetics and pharmacodynamics.
@en
prefLabel
Gender effects in pharmacokinetics and pharmacodynamics.
@en
P2093
P1433
P1476
Gender effects in pharmacokinetics and pharmacodynamics.
@en
P2093
J B Schwartz
R Z Harris
P304
P356
10.2165/00003495-199550020-00003
P577
1995-08-01T00:00:00Z
P6179
1027353958